Equally telling is the fact that upon withdrawal of curcumin, the relapse rate quickly paralleled that of patients treated initially with placebo—implying that curcumin was, in fact, exerting some important biologic effect.That’s the same thing a Cochrane review concluded in 2013: curcumin may be a safe and effective adjunct therapy.